Toros Dincman

566 total citations
17 papers, 367 citations indexed

About

Toros Dincman is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Toros Dincman has authored 17 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Toros Dincman's work include RNA Research and Splicing (4 papers), RNA modifications and cancer (3 papers) and DNA Repair Mechanisms (2 papers). Toros Dincman is often cited by papers focused on RNA Research and Splicing (4 papers), RNA modifications and cancer (3 papers) and DNA Repair Mechanisms (2 papers). Toros Dincman collaborates with scholars based in United States and France. Toros Dincman's co-authors include Scott R. Whittemore, Sujata Saraswat Ohri, Jason E. Beare, Lisa L. Steed, Don C. Rockey, Bidyut K. Mohanty, Philip H. Howe, Annamarie C. Dalton, Breege V. Howley and Simon Grelet and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Toros Dincman

16 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toros Dincman United States 9 156 68 59 57 56 17 367
Jenny Gu United States 8 104 0.7× 67 1.0× 17 0.3× 41 0.7× 16 0.3× 10 343
Andreas Muschaweckh Germany 12 146 0.9× 25 0.4× 10 0.2× 106 1.9× 39 0.7× 14 730
Lisa Hanson United States 7 159 1.0× 128 1.9× 14 0.2× 64 1.1× 17 0.3× 8 503
Basel T. Assaf United States 9 213 1.4× 30 0.4× 18 0.3× 44 0.8× 34 0.6× 17 394
Takako Shimada Japan 12 202 1.3× 4 0.1× 26 0.4× 44 0.8× 54 1.0× 34 470
Mitchell D. Krathwohl United States 8 100 0.6× 168 2.5× 90 1.5× 275 4.8× 22 0.4× 8 672
Yi Wei Zhang United States 7 102 0.7× 18 0.3× 67 1.1× 10 0.2× 8 0.1× 8 408
Lee M. Wheldon United Kingdom 13 384 2.5× 6 0.1× 22 0.4× 27 0.5× 27 0.5× 19 467
Klaus Heckelsmiller Germany 7 229 1.5× 7 0.1× 19 0.3× 147 2.6× 30 0.5× 13 816
Paul Baum United States 12 294 1.9× 94 1.4× 14 0.2× 62 1.1× 12 0.2× 17 773

Countries citing papers authored by Toros Dincman

Since Specialization
Citations

This map shows the geographic impact of Toros Dincman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toros Dincman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toros Dincman more than expected).

Fields of papers citing papers by Toros Dincman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toros Dincman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toros Dincman. The network helps show where Toros Dincman may publish in the future.

Co-authorship network of co-authors of Toros Dincman

This figure shows the co-authorship network connecting the top 25 collaborators of Toros Dincman. A scholar is included among the top collaborators of Toros Dincman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toros Dincman. Toros Dincman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Roeland, Eric, Mohamedtaki Abdulaziz Tejani, Eric Cheung, et al.. (2025). A phase 1b dose escalation study of AV-380 (anti-GDF15 monoclonal antibody) in combination with standard-of-care therapy in cancer patients with cachexia.. Journal of Clinical Oncology. 43(16_suppl).
2.
Mohanty, Bidyut K., Annamarie C. Dalton, Toros Dincman, et al.. (2024). The RNA-binding protein PCBP1 modulates transcription by recruiting the G-quadruplex-specific helicase DHX9. Journal of Biological Chemistry. 300(11). 107830–107830. 5 indexed citations
3.
Majumder, Mrinmoyee, Paramita Chakraborty, Hong Yu, et al.. (2024). RNA-binding protein HuR reprograms immune T cells and promotes oral squamous cell carcinoma. SHILAP Revista de lepidopterología. 10. 100296–100296. 1 indexed citations
4.
Dincman, Toros, Antonio Giordano, Hong Li, et al.. (2024). Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer. Frontiers in Oncology. 13. 1202277–1202277. 1 indexed citations
5.
Howley, Breege V., Bidyut K. Mohanty, Annamarie C. Dalton, et al.. (2022). The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression. Oncogene. 41(12). 1679–1690. 25 indexed citations
6.
Mohanty, Bidyut K., Breege V. Howley, Annamarie C. Dalton, et al.. (2021). Heterogeneous nuclear ribonucleoprotein E1 binds polycytosine DNA and monitors genome integrity. Life Science Alliance. 4(9). e202000995–e202000995. 8 indexed citations
7.
Gourdin, Theodore Stewart, Michelle M. Lilly, Arif Hussain, et al.. (2021). Preliminary results from a phase II trial of docetaxel before castration with degarelix in men with newly diagnosed metastatic prostate cancer.. Journal of Clinical Oncology. 39(6_suppl). 116–116. 2 indexed citations
8.
Woosley, Alec N., Annamarie C. Dalton, George S. Hussey, et al.. (2019). TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis. Oncogene. 38(20). 3794–3811. 69 indexed citations
9.
Dincman, Toros, et al.. (2018). Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1). Journal of Biological Chemistry. 293(29). 11401–11414. 13 indexed citations
10.
Dimou, Anastasios, Toros Dincman, Emilie Evanno, et al.. (2017). Epigenetics during EMT in lung cancer: EZH2 as a potential therapeutic target. Cancer Treatment and Research Communications. 12. 40–48. 7 indexed citations
11.
Dincman, Toros, Jason E. Beare, Sujata Saraswat Ohri, et al.. (2016). Histone deacetylase inhibition is cytotoxic to oligodendrocyte precursor cells in vitro and in vivo. International Journal of Developmental Neuroscience. 54(1). 53–61. 15 indexed citations
12.
Dincman, Toros, et al.. (2015). Clinical Features and Outcomes of Pasteurella multocida Infection. Medicine. 94(36). e1285–e1285. 81 indexed citations
13.
Dincman, Toros, Jason E. Beare, Sujata Saraswat Ohri, & Scott R. Whittemore. (2012). Isolation of cortical mouse oligodendrocyte precursor cells. Journal of Neuroscience Methods. 209(1). 219–226. 71 indexed citations
14.
Benton, Richard, Melissa A. Maddie, Toros Dincman, Theo Hagg, & Scott R. Whittemore. (2009). Transcriptional Activation of Endothelial Cells by TGFβ Coincides with Acute Microvascular Plasticity following Focal Spinal Cord Ischaemia/Reperfusion Injury. ASN NEURO. 1(3). 13 indexed citations
15.
Zhang, Yi Ping, Darlene A. Burke, Lisa B. E. Shields, et al.. (2008). Spinal Cord Contusion Based on Precise Vertebral Stabilization and Tissue Displacement Measured by Combined Assessment to Discriminate Small Functional Differences. Journal of Neurotrauma. 25(10). 1227–1240. 44 indexed citations
16.
Ertekin‐Taner, Nilüfer, Mariet Allen, Linda H. Younkin, et al.. (2006). P1–353: Associaton of VR22 and LRRTM3 variants with late onset Alzheimer's disease (LOAD) and amyloid beta levels. Alzheimer s & Dementia. 2(3S_Part_7). 1 indexed citations
17.
Strauss, Bernard S., et al.. (2004). Cell Death in Escherichia coli dnaE (Ts) Mutants Incubated at a Nonpermissive Temperature Is Prevented by Mutation in the cydA Gene. Journal of Bacteriology. 186(7). 2147–2155. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jenny Gu Breakdown of academic impact, for papers by Andreas Muschaweckh Breakdown of academic impact, for papers by Lisa Hanson Breakdown of academic impact, for papers by Basel T. Assaf Breakdown of academic impact, for papers by Takako Shimada Breakdown of academic impact, for papers by Mitchell D. Krathwohl Breakdown of academic impact, for papers by Yi Wei Zhang Breakdown of academic impact, for papers by Lee M. Wheldon Breakdown of academic impact, for papers by Klaus Heckelsmiller Breakdown of academic impact, for papers by Paul Baum
Rankless by CCL
2026